Andrew Boyer

Andrew Boyer

EVP, Chief Commercial Officer - GenericsatAmneal Pharmaceuticals· In proxies 2021–2025

Pay in FY2025+8% from the year before · Amneal Pharmaceuticals stock +59.1% the same year

Andrew Boyer was paid $3.0M in FY2025 (Dec), up 8%. Amneal Pharmaceuticals stock rose 59.1% that year.

Pay$100 in the stock at the end of FY20 → $276
Pay is from the Summary Compensation Table of each Amneal Pharmaceuticals proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Amneal PharmaceuticalsPublic company · 5 yr
    • EVP, Chief Commercial Officer - Generics2021 – Present · 5 yrStock in role +377%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?